Bill117th CongressFiled May 3, 2022Health
H.R. 7658
To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (May 3, 2022)
This bill reauthorizes through FY2027 the Food and Drug Administration's Critical Path Public-Private Partnerships, which support medical product innovation, development, and safety.
What just happenedMay 3, 2022
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. O'Halleran, Tom [D-AZ-1](D-AZ)Sponsor
1 cosponsor1 R
1cosponsors1committees3actions3related bills
- Introduced in HouseMay 3, 2022
- May 3, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - May 3, 2022IntroReferralIntro-H
Introduced in House
- May 3, 2022IntroReferral1000
Introduced in House